U.S. Markets close in 3 hrs 49 mins

Takeda CEO Sees Path to Survival in Shire Megadeal

Eric Pfanner, Jacqueline Simmons
Takeda CEO Sees Path to Survival in Shire Megadeal

This is pharma now, says Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber, and the outlook isn’t any better. Scale up, says the French executive who’s run Takeda since 2015 and is currently in London seeking investor support for its planned $62 billion takeover of Shire, whose gastroenterology, neuroscience and rare-disease businesses he says are critical to accelerating the company’s transformation. Just a week ago Takeda clinched a deal to take over Shire, a company that’s about 50 percent bigger than its Osaka-based buyer by market value.